These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

421 related items for PubMed ID: 7673023

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [Prognostic analysis of patients with cerebral glioma treated with radiotherapy].
    Wu SX, Deng ML, Li QQ, Zhao C, Lu TX, Li FY, Cui NJ.
    Ai Zheng; 2004 Nov; 23(11 Suppl):1561-6. PubMed ID: 15566680
    [Abstract] [Full Text] [Related]

  • 23. Phase II study of nimustine, carboplatin, vincristine, and interferon-beta with radiotherapy for glioblastoma multiforme: experience of the Kyoto Neuro-Oncology Group.
    Aoki T, Takahashi JA, Ueba T, Oya N, Hiraoka M, Matsui K, Fukui T, Nakashima Y, Ishikawa M, Hashimoto N.
    J Neurosurg; 2006 Sep; 105(3):385-91. PubMed ID: 16961130
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Randomized phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight-drugs-in-1-day regimen. Childrens Cancer Group.
    Finlay JL, Boyett JM, Yates AJ, Wisoff JH, Milstein JM, Geyer JR, Bertolone SJ, McGuire P, Cherlow JM, Tefft M.
    J Clin Oncol; 1995 Jan; 13(1):112-23. PubMed ID: 7799011
    [Abstract] [Full Text] [Related]

  • 28. Advantage of post-radiotherapy chemotherapy with CCNU, procarbazine, and vincristine (mPCV) over chemotherapy with VM-26 and CCNU for malignant gliomas.
    Jeremic B, Jovanovic D, Djuric LJ, Jevremovic S, Mijatovic LJ.
    J Chemother; 1992 Apr; 4(2):123-6. PubMed ID: 1321239
    [Abstract] [Full Text] [Related]

  • 29. Stereotactic radiosurgery as an adjunct to surgery and external beam radiotherapy in the treatment of patients with malignant gliomas.
    Gannett D, Stea B, Lulu B, Adair T, Verdi C, Hamilton A.
    Int J Radiat Oncol Biol Phys; 1995 Sep 30; 33(2):461-8. PubMed ID: 7673034
    [Abstract] [Full Text] [Related]

  • 30. Phase III comparison of BCNU and the combination of procarbazine, CCNU, and vincristine administered after radiotherapy with hydroxyurea for malignant gliomas.
    Levin VA, Wara WM, Davis RL, Vestnys P, Resser KJ, Yatsko K, Nutik S, Gutin PH, Wilson CB.
    J Neurosurg; 1985 Aug 30; 63(2):218-23. PubMed ID: 2991486
    [Abstract] [Full Text] [Related]

  • 31. Hyperfractionated radiation therapy (HFX RT) followed by multiagent chemotherapy (CHT) in patients with malignant glioma: a phase II study.
    Jeremic B, Grujicic D, Antunovic V, Djuric L, Stojanovic M, Shibamoto Y.
    Int J Radiat Oncol Biol Phys; 1994 Dec 01; 30(5):1179-85. PubMed ID: 7961028
    [Abstract] [Full Text] [Related]

  • 32. Open-label simultaneous radio-chemotherapy of glioblastoma multiforme with topotecan in adults.
    Gross MW, Altscher R, Brandtner M, Haeusser-Mischlich H, Chiricuta IC, Siegmann AD, Engenhart-Cabillic R.
    Clin Neurol Neurosurg; 2005 Apr 01; 107(3):207-13. PubMed ID: 15823676
    [Abstract] [Full Text] [Related]

  • 33. Postoperative radiotherapy of glioblastoma multiforme: analysis and critical assessment of different treatment strategies and predictive factors.
    Piroth MD, Gagel B, Pinkawa M, Stanzel S, Asadpour B, Eble MJ.
    Strahlenther Onkol; 2007 Dec 01; 183(12):695-702. PubMed ID: 18040615
    [Abstract] [Full Text] [Related]

  • 34. Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma.
    Buckner JC, Shaw EG, Pugh SL, Chakravarti A, Gilbert MR, Barger GR, Coons S, Ricci P, Bullard D, Brown PD, Stelzer K, Brachman D, Suh JH, Schultz CJ, Bahary JP, Fisher BJ, Kim H, Murtha AD, Bell EH, Won M, Mehta MP, Curran WJ.
    N Engl J Med; 2016 Apr 07; 374(14):1344-55. PubMed ID: 27050206
    [Abstract] [Full Text] [Related]

  • 35. Phase II trial of lomustine plus temozolomide chemotherapy in addition to radiotherapy in newly diagnosed glioblastoma: UKT-03.
    Herrlinger U, Rieger J, Koch D, Loeser S, Blaschke B, Kortmann RD, Steinbach JP, Hundsberger T, Wick W, Meyermann R, Tan TC, Sommer C, Bamberg M, Reifenberger G, Weller M.
    J Clin Oncol; 2006 Sep 20; 24(27):4412-7. PubMed ID: 16983109
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Locally delivered chemotherapy and repeated surgery can improve survival in glioblastoma patients.
    Boiardi A, Eoli M, Pozzi A, Salmaggi A, Broggi G, Silvani A.
    Ital J Neurol Sci; 1999 Feb 20; 20(1):43-8. PubMed ID: 10933484
    [Abstract] [Full Text] [Related]

  • 38. Radiation therapy and hydroxyurea followed by the combination of 6-thioguanine and BCNU for the treatment of primary malignant brain tumors.
    Prados MD, Larson DA, Lamborn K, McDermott MW, Sneed PK, Wara WM, Chang SM, Mack EE, Krouwer HG, Chandler KL, Warnick RE, Davis RL, Rabbitt JE, Malec M, Levin VA, Gutin PH, Phillips TL, Wilson CB.
    Int J Radiat Oncol Biol Phys; 1998 Jan 01; 40(1):57-63. PubMed ID: 9422558
    [Abstract] [Full Text] [Related]

  • 39. External irradiation followed by an interstitial high activity iodine-125 implant "boost" in the initial treatment of malignant gliomas: NCOG study 6G-82-2.
    Gutin PH, Prados MD, Phillips TL, Wara WM, Larson DA, Leibel SA, Sneed PK, Levin VA, Weaver KA, Silver P.
    Int J Radiat Oncol Biol Phys; 1991 Aug 01; 21(3):601-6. PubMed ID: 1651302
    [Abstract] [Full Text] [Related]

  • 40. Procarbazine, lomustine, and vincristine (PCV) chemotherapy for anaplastic astrocytoma: A retrospective review of radiation therapy oncology group protocols comparing survival with carmustine or PCV adjuvant chemotherapy.
    Prados MD, Scott C, Curran WJ, Nelson DF, Leibel S, Kramer S.
    J Clin Oncol; 1999 Nov 01; 17(11):3389-95. PubMed ID: 10550132
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.